Autologous chondrocyte implantation.

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials Science

Background:

• Cartilage damage in young patients requires understanding predisposing factors and disease stage.
• Autologous chondrocyte implantation (ACI) is a cell-based therapy for articular cartilage repair.
• Traditional marrow-stimulation techniques yield fibrocartilage, which is less durable than hyaline cartilage.

Purpose of the Study:

• To evaluate the efficacy of autologous chondrocyte implantation for various knee cartilage defects.
• To compare ACI outcomes with traditional cartilage repair methods.
• To provide treatment guidelines based on lesion characteristics and patient factors.

Main Methods:

• ACI involves implanting cultured chondrocytes into cartilage defects using an open surgical technique.
• Patient outcomes were assessed based on lesion location (femoral condyle, patella, tibia) and size.
• Follow-up included evaluation of tissue durability and functional recovery.

Main Results:

• ACI achieved good/excellent results in 90% of patients with isolated femoral condyle lesions.
• Approximately 75% of patients with patellar lesions improved, contingent on malalignment correction.
• Encouraging results for tibial and salvage lesions warrant caution due to limited follow-up data.

Conclusions:

• ACI offers a durable, hyaline-like tissue repair, superior to fibrocartilage from marrow stimulation.
• Treatment selection should align with patient expectations, lesion characteristics, and demographic factors.
• ACI is recommended for large defects (>2 cm²) as first-line therapy and for all lesion sizes as revision therapy after failed marrow stimulation.